Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ZIMI LIMITED AGM Information 2019

Oct 15, 2019

66122_rns_2019-10-15_e7f204f5-277e-4611-a52d-7c204f6367a4.pdf

AGM Information

Open in viewer

Opens in your device viewer

QUANTIFY TECHNOLOGY HOLDINGS LIMITED ACN 113 326 524

NOTICE OF ANNUAL GENERAL MEETING

TIME : 3.30pm DATE : 27 November 2019 PLACE : Ground Floor 216 St Georges Terrace Perth WA 6000

This Notice of Meeting should be read in its entirety. If Shareholders are in doubt as to how they should vote, they should seek advice from their professional advisers prior to voting.

Should you wish to discuss the matters in this Notice of Meeting please do not hesitate to contact the Company Secretary on +61 8 6268 2622.

CONTENTS

Business of the Meeting (setting out the proposed Resolutions) 3
Explanatory Statement (explaining the proposed Resolutions) 5
Glossary 14
Proxy Form 16
IMPORTANT INFORMATION

Time and place of Meeting

Notice is given that the Meeting will be held at 3.00 pm (WST) on Wednesday, 27 November 2019 at:

Ground Floor, 216 St Georges Terrace, Perth WA 6000

Your vote is important

The business of the Meeting affects your shareholding and your vote is important.

Voting eligibility

The Directors have determined pursuant to Regulation 7.11.37 of the Corporations Regulations 2001 (Cth) that the persons eligible to vote at the Meeting are those who are registered Shareholders at 4.00pm (WST) on 25 November 2019.

Voting in person

To vote in person, attend the Meeting at the time, date and place set out above.

Voting by proxy

To vote by proxy, please complete and sign the enclosed Proxy Form and return by the time and in accordance with the instructions set out on the Proxy Form.

In accordance with section 249L of the Corporations Act, Shareholders are advised that:

  • each Shareholder has a right to appoint a proxy;

  • the proxy need not be a Shareholder of the Company; and

  • a Shareholder who is entitled to cast 2 or more votes may appoint 2 proxies and may specify the proportion or number of votes each proxy is appointed to exercise. If the member appoints 2 proxies and the appointment does not specify the proportion or number of the member’s votes, then in accordance with section 249X(3) of the Corporations Act, each proxy may exercise one-half of the votes.

Sections 250BB and 250BC of the Corporations Act provide that:

  • if proxy holders vote, they must cast all directed proxies as directed; and

  • any directed proxies which are not voted will automatically default to the Chair, who must vote the proxies as directed.

1

Proxy vote if appointment specifies way to vote

Section 250BB(1) of the Corporations Act provides that an appointment of a proxy may specify the way the proxy is to vote on a particular resolution and, if it does :

  • the proxy need not vote on a show of hands, but if the proxy does so, the proxy must vote that way (ie as directed); and

  • if the proxy has 2 or more appointments that specify different ways to vote on the resolution, the proxy must not vote on a show of hands; and

  • if the proxy is the chair of the meeting at which the resolution is voted on, the proxy must vote on a poll, and must vote that way (ie as directed); and

  • if the proxy is not the chair, the proxy need not vote on the poll, but if the proxy does so, the proxy must vote that way (ie as directed).

Transfer of non-chair proxy to chair in certain circumstances

Section 250BC of the Corporations Act provides that, if:

  • an appointment of a proxy specifies the way the proxy is to vote on a particular resolution at a meeting of the Company's members; and

  • the appointed proxy is not the chair of the meeting; and

  • at the meeting, a poll is duly demanded on the resolution; and

  • either of the following applies:

  • the proxy is not recorded as attending the meeting; or

  • the proxy does not vote on the resolution,

the chair of the meeting is taken, before voting on the resolution closes, to have been appointed as the proxy for the purposes of voting on the resolution at the meeting.

2

BUSINESS OF THE MEETING

AGENDA

FINANCIAL STATEMENTS AND REPORTS

To receive and consider the annual financial report of the Company for the financial year ended 30 June 2019 together with the declaration of the directors, the director’s report, the Remuneration Report and the auditor’s report.

1. RESOLUTION 1 – ADOPTION OF REMUNERATION REPORT

To consider and, if thought fit, to pass the following resolution as a non-binding resolution :

“That, for the purposes of section 250R(2) of the Corporations Act and for all other purposes, approval is given for the adoption of the Remuneration Report as contained in the Company’s annual financial report for the financial year ended 30 June 2019.”

Note: the vote on this Resolution is advisory only and does not bind the Directors or the Company.

Voting Prohibition Statement:

A vote on this Resolution must not be cast (in any capacity) by or on behalf of either of the following persons:

  • (a) a member of the Key Management Personnel, details of whose remuneration are included in the Remuneration Report; or

  • (b) a Closely Related Party of such a member.

However, a person (the voter ) described above may cast a vote on this Resolution as a proxy if the vote is not cast on behalf of a person described above and either:

  • (a) the voter is appointed as a proxy by writing that specifies the way the proxy is to vote on this Resolution; or

  • (b) the voter is the Chair and the appointment of the Chair as proxy:

  • (i) does not specify the way the proxy is to vote on this Resolution; and

  • (ii) expressly authorises the Chair to exercise the proxy even though this Resolution is connected directly or indirectly with the remuneration of a member of the Key Management Personnel.

2. RESOLUTION 2 – RE-ELECTION OF DIRECTOR – GARY CASTLEDINE

To consider and, if thought fit, to pass the following resolution as an ordinary resolution :

“That, for the purpose of clause 58 of the Constitution and for all other purposes, Gary Castledine, a Director, retires by rotation, and being eligible, is re-elected as a Director.”

3. RESOLUTION 3 – APPROVAL OF 10% PLACEMENT CAPACITY

To consider and, if thought fit, to pass the following resolution as a special resolution :

That, for the purpose of ASX Listing Rule 7.1A and for all other purposes, approval is given for the issue of Equity Securities totalling up to 10% of the Shares on issue, calculated in accordance with the formula prescribed in Listing Rule 7.1A.2 and on the terms and conditions set out in the Explanatory Statement forming part of this Notice.

3

Voting Exclusion : The Company will disregard any votes cast in favour of this Resolution by or on behalf of a person who is expected to participate in, or who will obtain a material benefit as a result of, the proposed issue (except a benefit solely by reason of being a holder of ordinary securities) or any associate of those persons. However, the Company need not disregard a vote if it is cast by a person as a proxy for a person who is entitled to vote, in accordance with the directions on the Proxy Form, or, it is cast by the person chairing the meeting as proxy for a person who is entitled to vote, in accordance with a direction on the Proxy Form to vote as the proxy decides.

Dated: 8 October 2019

By order of the Board

==> picture [86 x 39] intentionally omitted <==

Neville Bassett Company Secretary

4

E X P L A N A T O RY S T A TE M E N T

This Explanatory Statement has been prepared to provide information which the Directors believe to be material to Shareholders in deciding whether or not to pass the Resolutions.

The Directors recommend that Shareholders vote in favour of all Resolutions.

1. FINANCIAL STATEMENTS AND REPORTS

In accordance with the Constitution, the business of the Meeting will include receipt and consideration of the annual financial report of the Company for the financial year ended 30 June 2019 together with the declaration of the directors, the directors’ report, the Remuneration Report and the auditor’s report.

The Company will not provide a hard copy of the Company’s annual financial report to Shareholders unless specifically requested to do so. The Company’s annual financial report is available on its website at http://www.quantifytechnology.com

2. RESOLUTION 1 – ADOPTION OF REMUNERATION REPORT

2.1 General

The Corporations Act requires that at a listed company’s annual general meeting, a resolution that the remuneration report be adopted must be put to the shareholders. However, such a resolution is advisory only and does not bind the company or the directors of the company.

The remuneration report sets out the company’s remuneration arrangements for the directors and senior management of the company. The remuneration report is part of the directors’ report contained in the annual financial report of the company for a financial year.

The chair of the meeting must allow a reasonable opportunity for its shareholders to ask questions about or make comments on the remuneration report at the annual general meeting.

2.2 Voting consequences

A company is required to put to its shareholders a resolution proposing the calling of another meeting of shareholders to consider the appointment of directors of the company ( Spill Resolution ) if, at consecutive annual general meetings, at least 25% of the votes cast on a remuneration report resolution are voted against adoption of the remuneration report and at the first of those annual general meetings a Spill Resolution was not put to vote. If required, the Spill Resolution must be put to vote at the second of those annual general meetings.

If more than 50% of votes cast are in favour of the Spill Resolution, the company must convene a shareholder meeting ( Spill Meeting ) within 90 days of the second annual general meeting.

All of the directors of the company who were in office when the directors' report (as included in the company’s annual financial report for the most recent financial year) was approved, other than the managing director of the company, will cease to hold office immediately before the end of the Spill Meeting but may stand for re-election at the Spill Meeting.

Following the Spill Meeting those persons whose election or re-election as directors of the company is approved will be the directors of the company.

2.3 Previous voting results

At the Company’s previous annual general meeting the votes cast against the remuneration report considered at that annual general meeting were less than 25%. Accordingly, the Spill Resolution is not relevant for this Annual General Meeting.

5

3. RESOLUTION 2 – RE-ELECTION OF DIRECTOR – GARY CASTLEDINE

3.1 General

The Company’s Constitution requires that one third of the Company’s directors must retire at each AGM. Accordingly, Mr Castledine will retire by rotation and, being eligible, offers himself for re-election.

3.2 Qualifications and experience

A summary of the qualifications and experience of Mr Castledine is provided in the Annual Report.

3.3 Board recommendation

The Board supports the re-election of Gary Castledine and recommends that Shareholders vote in favour of Resolution 2.

4. RESOLUTION 3 – APPROVAL OF 10% PLACEMENT CAPACITY

4.1 General

ASX Listing Rule 7.1A provides that an Eligible Entity may seek Shareholder approval at its annual general meeting to allow it to issue Equity Securities up to 10% of its issued capital over a period up to 12 months after the annual general meeting ( 10% Placement Capacity ).

The Company is an Eligible Entity.

If Shareholders approve Resolution 3, the number of Equity Securities the Eligible Entity may issue under the 10% Placement Capacity will be determined in accordance with the formula prescribed in ASX Listing Rule 7.1A.2 (as set out in Section 4.2 below).

The effect of Resolution 3 will be to allow the Directors to issue Equity Securities up to 10% of the Company’s fully paid ordinary securities on issue under the 10% Placement Capacity during the period up to 12 months after the Meeting, without subsequent Shareholder approval and without using the Company’s 15% annual placement capacity granted under Listing Rule 7.1.

Resolution 3 is a special resolution. Accordingly, at least 75% of votes cast by Shareholders present and eligible to vote at the Meeting must be in favour of Resolution 3 for it to be passed.

4.2 ASX Listing Rule 7.1A

ASX Listing Rule 7.1A enables an Eligible Entity to seek shareholder approval at its annual general meeting to issue Equity Securities in addition to those under the Eligible Entity’s 15% annual placement capacity.

An Eligible Entity is one that, as at the date of the relevant annual general meeting:

  • (a) is not included in the S&P/ASX 300 Index; and

  • (b) has a maximum market capitalisation (excluding restricted securities and securities quoted on a deferred settlement basis) of $300,000,000.

The Company is an Eligible Entity as it is not included in the S&P/ASX 300 Index and has a current market capitalisation (at the date of this Explanatory Statement) of $5,968,153.

Any Equity Securities issued must be in the same class as an existing class of quoted Equity Securities. The Company currently has two classes of quoted Equity Securities on issue, being the Shares (ASX Code: QFY) and options (ASX Code: QFYOB).

6

The exact number of Equity Securities that the Company may issue under an approval under Listing Rule 7.1A will be calculated according to the following formula:

(A x D) – E

Where:

A is the number of Shares on issue 12 months before the date of issue or agreement:

  • (i) plus the number of Shares issued in the previous 12 months under an exception in ASX Listing Rule 7.2;

  • (ii) plus the number of partly paid shares that became fully paid in the previous 12 months;

  • (iii) plus the number of Shares issued in the previous 12 months with approval of holders of Shares under ASX Listing Rules 7.1 or 7.4; and

  • (iv) less the number of Shares cancelled in the previous 12 months.

  • D is 10%.

  • E is the number of Equity Securities issued or agreed to be issued under ASX Listing Rule 7.1A.2 in the 12 months before the date of issue or agreement to issue that are not issued with the approval of holders of Ordinary Securities under ASX Listing Rule 7.1 or 7.4.

4.3 Technical information required by ASX Listing Rule 7.1A

Pursuant to and in accordance with ASX Listing Rule 7.3A, the information below is provided in relation to this Resolution 3:

(a) Minimum Price

The minimum price at which the Equity Securities may be issued is 75% of the volume weighted average price of Equity Securities in that class, calculated over the 15 ASX trading days on which trades in that class were recorded immediately before:

  • (i) the date on which the price at which the Equity Securities are to be issued is agreed; or

  • (ii) if the Equity Securities are not issued within 5 ASX trading days of the date in Section 8.3(a)(i), the date on which the Equity Securities are issued.

(b) Date of Issue

The Equity Securities may be issued under the 10% Placement Capacity commencing on the date of the Meeting and expiring on the first to occur of the following:

  • (i) 12 months after the date of this Meeting; and

  • (ii) the date of approval by Shareholders of any transaction under ASX Listing Rules 11.1.2 (a significant change to the nature or scale of the Company’s activities) or 11.2 (disposal of the Company’s main undertaking).

(c) Risk of voting dilution

Any issue of Equity Securities under the 10% Placement Capacity will dilute the interests of Shareholders who do not receive any Shares under the issue.

7

If Resolution 3 is approved by Shareholders and the Company issues the maximum number of Equity Securities available under the 10% Placement Capacity, the economic and voting dilution of existing Shares would be as shown in the table below.

The table below shows the dilution of existing Shareholders calculated in accordance with the formula outlined in ASX Listing Rule 7.1A(2), on the basis of the current market price of Shares and the number of Equity Securities currently on issue.

The table also shows the voting dilution impact where the number of Shares on issue (variable A in the formula) changes and the economic dilution where there are changes in the issue price of Shares issued under the 10% Placement Capacity.

Number of
Shares on Issue
Dilution
Number of
Shares issued
under 10%
Placement
Capacity
Funds raised
based on issue
price of $0.002
(50% decrease
in issue price)
Funds raised
based on issue
price of $0.004
(issue price)
Funds raised
based on issue
price of $0.008
(100%
increase in
issue price)
1,492,038,393
(Current)
149,203,839 $298,407 $596,815 $1,193,630
2,238,057,589
(50% increase)
223,805,759 $447,611 $895,223 $1,790,446
2,984,076,786
(100% increase)
298,407,679 $596,815 $1,193,630 $2,387,261

*The number of Shares on issue (variable A in the formula) could increase as a result of the issue of Shares that do not require Shareholder approval (such as under a pro-rata rights issue or scrip issued under a takeover offer) or that are issued with Shareholder approval under Listing Rule 7.1.

The table above uses the following assumptions:

  1. The current shares on issue are the Shares on issue as at 8 October 2019.

  2. The issue price set out above is the last closing price of the Shares on the ASX prior to the date of this Notice.

  3. The Company issues the maximum possible number of Equity Securities under the 10% Placement Capacity.

  4. The Company has not issued any Equity Securities in the 12 months prior to the Meeting that were not issued under an exception in ASX Listing Rule 7.2 or with approval under ASX Listing Rule 7.1.

  5. The calculations above do not show the dilution that any one particular Shareholder will be subject to. All Shareholders should consider the dilution caused to their own shareholding depending on their specific circumstances.

  6. This table does not set out any dilution pursuant to approvals under ASX Listing Rule 7.1.

Shareholders should note that there is a risk that:

  • (i) the market price for the Company’s Shares may be significantly lower on the issue date than on the date of the Meeting; and

  • (ii) the Shares may be issued at a price that is at a discount to the market price for those Shares on the date of issue.

8

(d) Purpose of Issue under 10% Placement Capacity

The Company may issue Equity Securities under the 10% Placement Capacity for the following purposes:

  • (i) as cash consideration in which case the Company intends to use funds raised for the continued commercialisation of Quantify’s IoT solution, including to advance revenue generating contracts, product licencing opportunities, as well as funding research and development, and for general working capital; or

  • (ii) as non-cash consideration for the acquisition of new assets and investments, in such circumstances the Company will provide a valuation of the non-cash consideration as required by listing Rule 7.1A.3.

(e) Allocation under the 10% Placement Capacity

The Company’s allocation policy is dependent on the prevailing market conditions at the time of any proposed issue pursuant to the 10% Placement Capacity. The identity of the allottees of Equity Securities will be determined on a case-by-case basis having regard to a number of factors, including:

  • (i) the purpose of the issue;

  • (ii) alternative methods for raising funds available to the Company at that time, including, but not limited to, an entitlement issue or other offer where existing Shareholders may participate;

  • (iii) the effect of the issue of the Equity Securities on the control of the Company;

  • (iv) the circumstances of the Company, including, but not limited to, the financial position and solvency of the Company; and

  • (v) advice from corporate, financial and broking advisers (if applicable).

The allottees under the 10% Placement Capacity have not been determined as at the date of this Notice but may include existing Shareholders and/or new investors who are not related parties or associates of a related party of the Company.

Further, if the Company is successful in acquiring new assets or investments, it is possible that the allottees under the 10% Placement Capacity will be the vendors of the new assets or investments.

(f) Previous Approval under ASX Listing Rule 7.1A

The Company previously obtained approval under ASX Listing Rule 7.1A at its annual general meeting held on 30 November 2018.

In accordance with ASX Listing Rule 7.3A.6, the following information is provided to shareholders regarding the equity securities issued in the previous 12 months preceding the date of the Annual General Meeting.

Listing Rule 7.3A.6(a)

The table below shows the total number of equity securities issued in the previous 12 months preceding the date of the annual general meeting and the percentage that those issues represent of the total number of equity securities on issue at the commencement of that 12 month period.


ommencement of that 12 month period.
Total number of equity securities issued in the 12 months
preceding the date of the meeting
1,077,495,355
Percentage that they represent of the total number of
equity securities on issue at the commencement of that
12 month period
88.2%

9

Date of issue 20 December 2018
Number issued 80,000,000 Performance Shares
Summary of terms 20,000,000 Tranche 1 expiring 19 December
2023
20,000,000 Tranche 2 expiring 19 December
2023
40,000,000 Tranche 3 expiring 19 December
2023
Conversion – 1 for 1
Subject
to
performance
milestones
as
approved by shareholders on 30 November
2018.
Names of the persons who received
securities or basis on which those
persons were determined
Directors of the Company as approved by
shareholders on 30 November 2018
Price Nil – Partof remunerationpackage
Discount to market price (if any) N/A
For cash issues
Total cash consideration received N/A
Amount of cash consideration spent N/A
Use of cash consideration N/A
Intended use for remaining amount of
cash (if any)
N/A
For non-cash issues
Non-cash consideration paid Incentive as part of remuneration package
Current
value
of
that
non-cash
consideration
$320,000 based on current share price and
assuming performance conditions satisfied.
Date of issue 20 May 2019
Number issued 6,000,000 fully paid ordinary shares
Summary of terms Ordinary fully paid shares ranking equally
with existing shares on issue.
Names of the persons who received
securities or basis on which those
persons were determined
Selected
employees
pursuant
to
the
Quantify Employee Share Plan.
Price Nil–Part of remuneration package
Discount tomarketprice (ifany) N/A
For cash issues
Totalcashconsideration received N/A
Amount of cash consideration spent N/A
Use of cash consideration N/A
Intended use for remaining amount of
cash (if any)
N/A
For non-cash issues
Non-cash consideration paid Incentive as part of remuneration package
Current
value
of
that
non-cash
consideration
$24,000

10

Date of issue 20 May 2019
Number issued 2,999,997 employee share scheme shares
Summary of terms EES shares converting to ordinary fully paid
shares (1 for 1 ratio), for nil consideration, on
satisfying service condition.
Names of the persons who received
securities or basis on which those
personswere determined
Selected
employees
pursuant
to
the
Quantify Employee Share Plan.
Price Nil–Part of remuneration package
Discount to market price (if any) N/A
For cash issues
Total cash consideration received N/A
Amountofcashconsiderationspent N/A
Use of cash consideration N/A
Intended use for remaining amount of
cash(ifany)
N/A
For non-cash issues
Non-cashconsiderationpaid Incentive as partof remunerationpackage
Current
value
of
that
non-cash
consideration
$12,000
For non-cash issues
Non-cashconsiderationpaid
Current
value
of
that
non-cash
consideration
Incentive as partof remunerationpackage
$12,000
Date of issue 20 May 2019
Number issued 18,000,000 performance rights
Summary of terms Performance Rights converting to ordinary
fully paid shares (1 for 1 ratio), for nil
consideration,
on
satisfying
vesting
conditions as detailed in the Appendix 3B
lodged with ASX on 20 May 2019.
Names of the persons who received
securities or basis on which those
persons were determined
Selected
employees
pursuant
to
the
Quantify Employee Share Plan.
Price Nil–Part of remuneration package
Discount tomarketprice (ifany) N/A
For cash issues
Totalcashconsideration received N/A
Amount of cash consideration spent N/A
Use of cash consideration N/A
Intended use for remaining amount of
cash (if any)
N/A
For non-cash issues
Non-cash consideration paid Incentive as part of remuneration package
Current
value
of
that
non-cash
consideration
$72,000
consideration
Date of issue 2 July 2019 and 20 August 2019
Number issued 160,000,000 fully paid ordinary shares
160,000,000 options ($0.01;13/8/2021)
Summary of terms Ordinary fully paid shares ranking equally with
existing shares on issue.
Options exercisable at $0.01 each on or
before 13 August 2021.

11

Names of the persons who received
securities or basis on which those
persons were determined
Sophisticated and professional investors
Price $0.005 per share and nil per option
Discount to market price (if any) 16.67%
For cash issues
Total cash consideration received $800,000
Amount of cash consideration spent $630,775
Use of cash consideration Funds to be used to advance revenue
generating contracts and product licencing
opportunities, as well as fund research and
development, marketing, working capital and
general corporate expenditure.
Intended use for remaining amount
of cash (if any)
Unspent funds: $169,225
Funds to be used to advance revenue
generating contracts and product licencing
opportunities, as well as fund research and
development, marketing, working capital and
general corporate expenditure.
For non-cash issues
Non-cash consideration paid N/A
Current value of that non-cash
consideration
N/A
For non-cash issues
Non-cash consideration paid
Current value of that non-cash
consideration
N/A
N/A
Date of issue 20 August 2019
Number issued 40,000,000 fully paid ordinary shares
40,000,000 options ($0.01;13/8/2021)
Summary of terms Ordinary fully paid shares ranking equally with
existing shares on issue.
Options exercisable at $0.01 each on or
before13August 2021.
Names of the persons who received
securities or basis on which those
persons were determined
Directors pursuant to approval of shareholders
on 12 August 2019
Price $0.005 per share and nil per option
Discount to market price (if any) 16.67%
For cash issues
Total cash consideration received $200,000
Amount of cash consideration spent $157,694
Use of cash consideration Funds to be used to advance revenue
generating contracts and product licencing
opportunities, as well as fund research and
development, marketing, working capital and
general corporate expenditure.
Intended use for remaining amount
of cash (if any)
Unspent funds: $42,306
Funds to be used to advance revenue
generating contracts and product licencing
opportunities, as well as fund research and
development, marketing, working capital and
general corporate expenditure.

12

For non-cash issues
Non-cashconsiderationpaid N/A
Current value of that non-cash
consideration
N/A
Date of issue 14 August 2019 and 20 August 2019
Number issued 285,247,679 fully paid ordinary shares
285,247,689 options ($0.01; 13/8/2021)
Summary of terms Ordinary fully paid shares ranking equally with
existing shares on issue.
Options exercisable at $0.01 each on or
before 13 August 2021.
Names of the persons who received
securities or basis on which those
persons were determined
Entitlement issue to eligible shareholders.
Price $0.005 per share and nil per option
Discount to market price (if any) 16.67%
For cash issues
Total cash consideration received $1,426,238
Amount of cash consideration spent $1,124,544
Use of cash consideration Funds to be used to advance revenue
generating contracts and product licencing
opportunities, as well as fund research and
development, marketing, working capital and
general corporate expenditure.
Intended use for remaining amount
of cash (if any)
Unspent funds: $301,694
Funds to be used to advance revenue
generating contracts and product licencing
opportunities, as well as fund research and
development, marketing, working capital and
general corporate expenditure.
For non-cash issues
Non-cash consideration paid N/A
Current value of that non-cash
consideration
N/A

4.4 Voting Exclusion

A voting exclusion statement is included in this Notice. As at the date of this Notice, the Company has not invited any existing Shareholder to participate in an issue of Equity Securities under ASX Listing Rule 7.1A. Therefore, no existing Shareholders will be excluded from voting on Resolution 3.

13

G L O S S A RY

$ means Australian dollars.

ASIC means the Australian Securities & Investments Commission.

ASX means ASX Limited (ACN 008 624 691) or the financial market operated by ASX Limited, as the context requires.

ASX Listing Rules means the Listing Rules of ASX.

Board means the current board of directors of the Company.

Business Day means Monday to Friday inclusive, except New Year’s Day, Good Friday, Easter Monday, Christmas Day, Boxing Day, and any other day that ASX declares is not a business day.

Chair means the chair of the Meeting.

Closely Related Party of a member of the Key Management Personnel means:

  • (a) a spouse or child of the member;

  • (b) a child of the member’s spouse;

  • (c) a dependent of the member or the member’s spouse;

  • (d) anyone else who is one of the member’s family and may be expected to influence the member, or be influenced by the member, in the member’s dealing with the entity;

  • (e) a company the member controls; or

  • (f) a person prescribed by the Corporations Regulations 2001 (Cth) for the purposes of the definition of ‘closely related party’ in the Corporations Act.

Company or Quantify means Quantify Technology Holdings Limited (ACN 113 326 524).

Constitution means the Company’s constitution.

Corporations Act means the Corporations Act 2001 (Cth).

Directors means the current directors of the Company.

Equity Securities includes a Share, a right to a Share or Option, an Option, a convertible security and any security that ASX decides to classify as an Equity Security.

Explanatory Statement means the explanatory statement accompanying the Notice.

Key Management Personnel has the same meaning as in the accounting standards issued by the Australian Accounting Standards Board and means those persons having authority and responsibility for planning, directing and controlling the activities of the Company, or if the Company is part of a consolidated entity, of the consolidated entity, directly or indirectly, including any director (whether executive or otherwise) of the Company, or if the Company is part of a consolidated entity, of an entity within the consolidated group.

Meeting means the meeting convened by the Notice.

Notice or Notice of Meeting means this notice of meeting including the Explanatory Statement and the Proxy Form.

14

Ordinary Securities has the meaning set out in the ASX Listing Rules.

Proxy Form means the proxy form accompanying the Notice.

Remuneration Report means the remuneration report set out in the Director’s report section of the Company’s annual financial report for the year ended 30 June 2019.

Resolutions means the resolutions set out in the Notice, or any one of them, as the context requires.

Share means a fully paid ordinary share in the capital of the Company.

Shareholder means a registered holder of a Share.

WST means Western Standard Time as observed in Perth, Western Australia.

15

PROXY FORM

QUANTIFY TECHNOLOGY HOLDINGS LIMITED ACN 113 326 524

ANNUAL GENERAL MEETING

I/We

of: being a Shareholder entitled to attend and vote at the Meeting, hereby appoint: Name:

OR: the Chair of the Meeting as my/our proxy.

or failing the person so named or, if no person is named, the Chair, or the Chair’s nominee, to vote in accordance with the following directions, or, if no directions have been given, and subject to the relevant laws as the proxy sees fit, at the Meeting to be held at 3.30 pm, on 27 November 2019 at Ground Floor, 216 St Georges Terrace, Perth WA 6000, and at any adjournment thereof.

AUTHORITY FOR CHAIR TO VOTE UNDIRECTED PROXIES ON REMUNERATION RELATED RESOLUTION

Where I/we have appointed the Chair as my/our proxy (or where the Chair becomes my/our proxy by default), I/we expressly authorise the Chair to exercise my/our proxy on Resolution 1 (except where I/we have indicated a different voting intention below) even though Resolution 1 is connected directly or indirectly with the remuneration of a member of the Key Management Personnel, which includes the Chair.

CHAIR’S VOTING INTENTION IN RELATION TO UNDIRECTED PROXIES

The Chair intends to vote undirected proxies in favour of all Resolutions. In exceptional circumstances the Chair may change his/her voting intention on any Resolution. In the event this occurs an ASX announcement will be made immediately disclosing the reasons for the change.

Voting on business of the Meeting Voting on business of the Meeting FOR AGAINST ABSTAIN
Resolution 1 Adoption of Remuneration Report
Resolution 2 Re-election of Director – Gary Castledine
Resolution 3 Approval of 10% Placement Capacity

Please note : If you mark the abstain box for a particular Resolution, you are directing your proxy not to vote on that Resolution on a show of hands or on a poll and your votes will not be counted in computing the required majority on a poll.

If two proxies are being appointed, the proportion of voting rights this proxy represents is: % Signature of Shareholder(s): Individual or Shareholder 1 Shareholder 2 Shareholder 3 Sole Director/Company Secretary Director Director/Company Secretary

Date:

16

Instructions for completing Proxy Form

  1. ( Appointing a proxy ): A Shareholder entitled to attend and cast a vote at the Meeting is entitled to appoint a proxy to attend and vote on their behalf at the Meeting. If a Shareholder is entitled to cast 2 or more votes at the Meeting, the Shareholder may appoint a second proxy to attend and vote on their behalf at the Meeting. However, where both proxies attend the Meeting, voting may only be exercised on a poll. The appointment of a second proxy must be done on a separate copy of the Proxy Form. A Shareholder who appoints 2 proxies may specify the proportion or number of votes each proxy is appointed to exercise. If a Shareholder appoints 2 proxies and the appointments do not specify the proportion or number of the Shareholder’s votes each proxy is appointed to exercise, each proxy may exercise one-half of the votes. Any fractions of votes resulting from the application of these principles will be disregarded. A duly appointed proxy need not be a Shareholder.

  2. ( Direction to vote ): A Shareholder may direct a proxy how to vote by marking one of the boxes opposite each item of business. The direction may specify the proportion or number of votes that the proxy may exercise by writing the percentage or number of Shares next to the box marked for the relevant item of business. Where a box is not marked the proxy may vote as they choose subject to the relevant laws. Where more than one box is marked on an item the vote will be invalid on that item.

  3. ( Signing instructions ):

  4. ( Individual ): Where the holding is in one name, the Shareholder must sign.

  5. ( Joint holding ): Where the holding is in more than one name, all of the Shareholders should sign.

  6. ( Power of attorney ): If you have not already provided the power of attorney with the registry, please attach a certified photocopy of the power of attorney to this Proxy Form when you return it.

  7. ( Companies ): Where the company has a sole director who is also the sole company secretary, that person must sign. Where the company (pursuant to Section 204A of the Corporations Act) does not have a company secretary, a sole director can also sign alone. Otherwise, a director jointly with either another director or a company secretary must sign. Please sign in the appropriate place to indicate the office held. In addition, if a representative of a company is appointed pursuant to Section 250D of the Corporations Act to attend the Meeting, the documentation evidencing such appointment should be produced prior to admission to the Meeting. A form of a certificate evidencing the appointment may be obtained from the Company.

  8. ( Attending the Meeting ): Completion of a Proxy Form will not prevent individual Shareholders from attending the Meeting in person if they wish. Where a Shareholder completes and lodges a valid Proxy Form and attends the Meeting in person, then the proxy’s authority to speak and vote for that Shareholder is suspended while the Shareholder is present at the Meeting.

  9. ( Return of Proxy Form ): To vote by proxy, please complete and sign the enclosed Proxy Form and return by:

  10. (a) In person to C/- Westar Capital Limited, Level 4, 216 St Georges Terrace, Perth, WA

  11. (b) post to Quantify Technology Holdings Limited, PO Box 7315, Perth, WA 6850; or

  12. (c) facsimile to the Company on facsimile number +61 8 6268 2699; or

  13. (d) by email to [email protected]

so that it is received not less than 48 hours prior to commencement of the Meeting.

Proxy Forms received later than this time will be invalid.

17